glp-1 news 2025 october 16 KFF's survey of Medicaid officials found state Medicaid programs covered GLP-1s for obesity treatment as of 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC 🤯 Half your operatory is

Read More: How weight-loss drugs are destroying big snacking, erasing billions in sales Markets, regulation and stakes for Big Pharma Investors wasted little time reacting

How to Choose a Reliable Supplier for KPV and BPC-157 Request batch-matched third-party COAs for each compound separately Confirm sequence and molecular weight are explicitly disclosed, not just a purity percentage Look for RUO labeling with no human-use dosing language on either product Ask about US-based manufacturing and quality-control practices Check for a documented policy on batch replacement if a COA doesn't match on arrival Key Takeaways KPV is a small anti-inflammatory tripeptide derived from alpha-MSH

For this reason, BPC-157 studies should ideally report analytical verification, solvent conditions, storage conditions, reconstitution approach, experimental timing, concentration or exposure parameters appropriate to the model, and endpoint definitions

(Please gently swirl or invert the vial before each use to ensure even distribution.) Follow sterile procedures throughout the process